Aaron Kowalski

Directeur Général chez

JDRF International

Commercial Services

Consumer Services

Finance

Profil

Aaron J.
Kowalski is currently President, CEO & Chief Mission Officer at JDRF International since 2014 and Chief Executive Officer at Jdrf.
Formerly, Dr. Kowalski was a Board Member at A Breakthrough T1D Venture LLC.
Education includes undergraduate and doctorate degrees from Rutgers State University of New Jersey.

Postes actifs de Aaron Kowalski

Sociétés	Poste	Début
JDRF International JDRF International Miscellaneous Commercial ServicesCommercial Services Performs research & development on diabetes	Directeur Général	01/04/2019
Jdrf Jdrf Miscellaneous Commercial ServicesCommercial Services Provides fund raising services for type 1 diabetes	Directeur Général	-

Tous les postes actifs de Aaron Kowalski

Anciens postes connus de Aaron Kowalski

Sociétés	Poste	Fin
JDRF T1D Fund JDRF T1D Fund Investment ManagersFinance T1D Fund invests in companies located across the globe. The firm focuses on health technology sector. It participates in early stage capital requirements.	Directeur/Membre du Conseil	-

Voir l'expérience en détail de Aaron Kowalski

Formation de Aaron Kowalski

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Aaron Kowalski

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées	4
Rutgers State University of New Jersey Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
JDRF International JDRF International Miscellaneous Commercial ServicesCommercial Services Performs research & development on diabetes	Commercial Services
Jdrf Jdrf Miscellaneous Commercial ServicesCommercial Services Provides fund raising services for type 1 diabetes	Commercial Services
JDRF T1D Fund JDRF T1D Fund Investment ManagersFinance T1D Fund invests in companies located across the globe. The firm focuses on health technology sector. It participates in early stage capital requirements.	Finance